Research programme: siRNA conjugates - Annam Biosciences
Alternative Names: siRNACs - Annam BiosciencesLatest Information Update: 18 May 2023
At a glance
- Originator Annam Biosciences
- Class Antineoplastics; Drug conjugates; Small interfering RNA; Small molecules
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 11 May 2023 Early research in Cancer in USA (unspecified route) (Annam Biosciences pipeline, May 2023)
- 06 Mar 2014 Annam Biosciences has patent pending for N-boc-dendrimers and their conjugates in Worldwide
- 06 Mar 2014 Annam Biosciences has patent protection for N-boc-dendrimers and their conjugates in USA